Women's Health

The Pharmacy Times® Women’s Health resource center provides clinical news and articles, pertaining to women’s wellness, nutrition, fitness, weight loss, and answers to other potentially more intimate questions.

What can we help you find?

New Treatment for Osteoporosis In Postmenopausal Women is Available

Approved by the FDA on April 9, 2019, Amgen’s romosozumab-aqqg therapy (Evenity) is indicated for osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.

FDA Orders Safety Labeling Changes for Female Sexual Dysfunction Therapy

The action requires the company to revise safety information that women and their health care professionals need when considering use of the drug.

New Osteoporosis Therapy for Postmenopausal Women Granted FDA Approval

Romosozumab-aqqg (Evenity, Amgen) works to decrease the risk of fracture by increasing new bone formation in women with postmenopausal osteoporosis.

FDA Approves First Drug for Postpartum Depression

This therapy is expected to become available in late June.

Incorrect Tablet Arrangement Leads to Oral Contraceptive Recall

Indicating for preventing pregnancy, a statement from the FDA said that loss of efficacy is possible if the user misses tablets.

Survey: Women Want Information on PrEP

Many women are unaware of HIV pre-exposure prophylaxis (PrEP) but show a keen interest in spreading the word once they learn about the option, according a recent study in the journal Contraception.

Study Shows Pharmacists Can Increase Hormonal Contraceptive Adherence

A survey of sexually active women in the United States revealed that 29% experienced challenges in obtaining either a prescription or a refill for hormonal contraception.

Nausea in Pregnancy: Factors Influencing Decisions About Medication

Researchers at Kaiser Permanente Washington conducted a qualitative pilot study to understand the experiences and decision-making women face as they contemplate the use of antinausea medications during pregnancy.

Vulvodynia Study Endorsing Gabapentin for Pelvic Muscle Pain: An In-depth Look

Using a drug that increases GABA synthesis and possibly escalates intraneuronal dopamine in a population that is more likely to have behavior health concerns may prove to be an unsafe option.

FDA Approves Olaparib for BRCA-mutated Advanced Ovarian Cancer

Officials with the FDA have approved olaparib (Lynparza, AstraZeneca and MSD) for the maintenance treatment of adult patients with BRCA-mutated advanced ovarian cancer.

Oxybutynin May Provide Hot Flash Treatment Option in Breast Cancer Survivors

Hot flashes are a huge problem across the general population, but even more so in breast cancer survivors.

Monday Pharmaceutical Mystery: November 19

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

The Pharmacy Times® Women’s Health resource center page serves as a host for information about the most intricate questions surrounding women’s health issues.

Women have unique health issues, and some conditions and diseases that can be had by both sexes have the potential to impact women differently. Additionally, women should be keeping tabs on pregnancy, menopause, and conditions of the female organs; pharmacists can help. This resource center provides the latest clinical information, recent updates from a robust pipeline of novel therapies, and the newest data from all phases of clinical trials and studies in the space, allowing pharmacists to have an expert level of understanding of how to meet their customers’ needs.